Immunome Statistics Share Statistics Immunome has 87.05M
shares outstanding. The number of shares has increased by 44.89%
in one year.
Shares Outstanding 87.05M Shares Change (YoY) 44.89% Shares Change (QoQ) 0.07% Owned by Institutions (%) 91.76% Shares Floating 79.32M Failed to Deliver (FTD) Shares 417 FTD / Avg. Volume 0.04%
Short Selling Information The latest short interest is 14.2M, so 16.31% of the outstanding
shares have been sold short.
Short Interest 14.2M Short % of Shares Out 16.31% Short % of Float 17.04% Short Ratio (days to cover) 14.02
Valuation Ratios The PE ratio is -2.13 and the forward
PE ratio is -4.1.
Immunome's PEG ratio is
0.3.
PE Ratio -2.13 Forward PE -4.1 PS Ratio 68.88 Forward PS 54.5 PB Ratio 3.44 P/FCF Ratio -5.28 PEG Ratio 0.3
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Immunome.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 4.08,
with a Debt / Equity ratio of 0.03.
Current Ratio 4.08 Quick Ratio 4.08 Debt / Equity 0.03 Debt / EBITDA -0.03 Debt / FCF -0.04 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $69.02K Profits Per Employee $-2.24M Employee Count 131 Asset Turnover 0.04 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -23.58% in the
last 52 weeks. The beta is 1.93, so Immunome's
price volatility has been higher than the market average.
Beta 1.93 52-Week Price Change -23.58% 50-Day Moving Average 9.55 200-Day Moving Average 9.79 Relative Strength Index (RSI) 44.58 Average Volume (20 Days) 943,474
Income Statement In the last 12 months, Immunome had revenue of 9.04M
and earned -292.96M
in profits. Earnings per share was -5.
Revenue 9.04M Gross Profit 9.04M Operating Income -305.8M Net Income -292.96M EBITDA -151.35M EBIT -153.46M Earnings Per Share (EPS) -5
Full Income Statement Balance Sheet The company has 143.35M in cash and 4.83M in
debt, giving a net cash position of 138.52M.
Cash & Cash Equivalents 143.35M Total Debt 4.83M Net Cash 138.52M Retained Earnings -515.77M Total Assets 342.69M Working Capital 292.33M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -110.79M
and capital expenditures -7.17M, giving a free cash flow of -117.97M.
Operating Cash Flow -110.79M Capital Expenditures -7.17M Free Cash Flow -117.97M FCF Per Share -2.01
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -3382.37% and -3240.38%.
Gross Margin 100% Operating Margin -3382.37% Pretax Margin -3240.38% Profit Margin -3240.38% EBITDA Margin -1674.08% EBIT Margin -3382.37% FCF Margin -1304.8%
